DC Residents Aged 21+ Can Now Access Medical Cannabis ‘Immediately’ After Self-Certifying

Washington D.C. residents aged 21 and older can now access a temporary medical cannabis authorization card “immediately” after applying for medical cannabis access, according to a press release.

The temporary cards are good for 30 days while patient applications are being processed. Once granted, a temporary card will allow purchases at any of D.C.’s legal cannabis shops. When an application is approved, residents will receive both a digital and physical copy of their card, the report says.

The change, reported by the D.C. Alcoholic Beverage Regulation Administration (ABRA), comes on the heels of a significant policy change in July that allows D.C. residents to self-certify themselves for medical cannabis, rather than needing to see a health care practitioner. There are four licensed dispensary locations in the District.

Due to federal oversight, changes to D.C. laws must be approved by the House of Representatives, and because of this, the District has struggled to implement its own adult-use cannabis market despite becoming one of the very first U.S. jurisdictions to pass legalization in 2014. As a result, a cannabis “gifting” economy has flourished in D.C. where customers can buy unrelated products that come with a “gift” of cannabis.

End


British Columbia Workers Strike Impacting Cannabis Supply Chain

Workers in British Columbia, Canada went on strike this week, the Canadian Press reports. The British Columbia General Employees’ Union (BCGEU), which represents about 33,000 public-service workers across the province, set up picket lines at four BC Liquor Distribution Branch (BCLDB) wholesale and distribution centers on Monday.  

While retail cannabis and liquor stores are not part of the strike, which is over wages, the cannabis division of the Burnaby customer care center is part of the action and, in response, the BCLDB said its cannabis distribution center will not ship products, assemble orders, or process orders, and BC cannabis operators are bracing for disruption in supply. 

In a statement, the BCLDB said it “recognizes the current job action…may be concerning to wholesale and retail customers.” On its website, it apologized for any “impact” on businesses. 

“We do not know the extent of any future job action and therefore cannot speculate on the inventory levels held by wholesale customers nor customer demand and buying behaviors in this dynamic environment.” — BCLDB in a statement 

Omar Khan, the senior vice-president of corporate and public affairs for High Tide Inc., told the Press that the company is reallocating inventory from other stores in other provinces as they try to manage the situation but could still face “inventory issues.”  

“We urge the BCLDB and the BCGEU to resolve their dispute as soon as possible,” he told the Press, “as lack of inventory at licensed cannabis stores risks driving consumers back into the hands of the illicit market, which will endanger public health and drive much-needed revenue away from government coffers.” 

Last month, cannabis workers with the Syndicat Canadien de la Fonction Publique (SCFP), which is affiliated with the Fédération des Travailleurs et Travailleuses du Québec (FTQ), the largest trade union in Quebec, announced an indefinite strike. Mediation negotiations in that row began last week. 

End


Josh Wurzer: Leading a Multi-State Cannabis Testing Lab

The state-to-state patchwork of cannabis industry regulations typically makes any multi-state cannabis operation exceedingly complicated, and the same can be said for important auxiliary services such as lab testing.

We recently connected with Josh Wurzer, the co-founder and COOof SC Labs — a cannabis and hemp testing lab operating in California, Colorado, Michigan, and Oregon — to discuss expanding markets, lab protocols, and tips for finding a reputable lab testing partner.

This Q&A also covers the founding of SC Labs, the company’s future as it transitions to new leadership, and more!

Scroll down to read the full interview.


Ganjapreneur: What inspired you and co-founders Jeff Gray and Alec Dixon to found SC Labs?

Josh Wurzer: I was the lab director at Steep Hill lab, which was the first commercial cannabis testing lab in the world. At the time, Steep Hill was run by cannabis activists without any laboratory background. I really liked the idea behind Steep Hill but thought there was an opportunity to build a cannabis lab that looked more like the commercial laboratories I was familiar with, while staying firmly rooted in the cannabis movement. In 2010, I was introduced to my future partners Alec Dixon, Jeff Gray, and Ian Rice and pitched the idea to them. They were all also working in the cannabis industry in various capacities and they immediately saw the value in lab testing. Alec was working in hydroponics and Jeff was a cultivation consultant. Over the course of a couple beers we agreed we would found the lab.

Did the business plan always include scaling the cannabis lab into a nationwide operation?

We never wanted to be in every market and we still don’t. Early on there were only a couple viable markets that could support lab testing. As we became more and more successful and started to become the dominant lab in California, we naturally began looking to expand. Labs only work in mature markets and we were always careful not to chase every opportunity or shiny object so we didn’t get too far ahead of ourselves.

How does the company decide the next state or territory it will expand into?

Today there are several viable testing markets. We generally look for emerging markets in states with large populations. One of our differentiators is in offering a consistent service, across markets, to clients who are also in multiple markets. As such, we look for states with a healthy number of multi-state operators.

In a market filled with lab shopping for the desired results, why can consumers and businesses trust SC Labs?

We have only been testing under state regulations for a small portion of the time the lab has been in existence. Early on, it was a tough sell walking into a dispensary asking for money and cannabis products with the promise of returning a PDF with some numbers on it. All we had was our integrity in the scientific rigor that went into producing those numbers. At the time, the people who were interested in voluntary testing were not looking to cheat either. So, building a trusted brand was central to the conversation. As such, we worked really hard to make sure we were never perceived as inflating results or any other unscrupulous behavior. The whole lab shopping and THC-inflation phenomenon came about with the advent of regulations requiring everyone to test.

Today, we still see our integrity and reputation as our most valuable asset and we guard it above all else. The scientists and support staff that work for SC Labs all take great pride in what we do. We do great work and we are always striving to improve the accuracy and quality of our test methods.

I believe some of the labs and cannabis producers who are chasing inflated THC results or trying to sneak contaminated cannabis goods into the supply chain are really short sighted. Most of the lab operators and our cannabis customers who are looking to build companies and brands that will stand the test of time understand that accuracy and integrity are more important than a quick buck.

How often does lab protocol require equipment to be cleaned, maintained, and calibrated?

It is different for every piece of equipment. Some equipment needs daily maintenance or calibration and some can go much longer without either. However, all of our analytical test methods require us to run multiple quality control samples with every test batch. This allows us to continuously monitor the calibration and performance of our equipment. Each of these quality control samples has acceptance criteria. If an instrument returns results outside of that criteria, it triggers an investigation into the cause and the batch has to be retested until we have passing quality control samples.

Does each lab have the same operations, standards, and offerings despite varying state regulations?

In some states, all the labs run all of the required tests and in other states, where it is allowed, some labs may specialize in a particular test or tests and subcontract the rest of the testing out to another lab. Our labs also offer specialized hemp tests that are compliant in all 50 states as well as several tests that aren’t required anywhere but may help our customers grow better cannabis, or make better cannabis products. Several of these tests aren’t really offered anywhere else. So in that regard, we are different. However, most of the cannabis labs have similar equipment and perform the same tests similarly.

Can you share any red (or green!) flags for industry operators who are currently looking for a reputable testing lab?

I would definitely be leery of labs who are willing to guarantee any results on a test. It sounds obvious, but it is impossible for laboratories to promise that you will get a certain result and if they do, test at your own risk. Additionally, lab customers should always vet their lab thoroughly and, if they have the resources, request the opportunity to audit a potential lab’s quality control system. A reputable laboratory should welcome this request and make themselves readily available for an on site visit as well as be willing to open up their operating procedures, quality and training records, etc. for review. If a laboratory welcomes this activity it is a good sign that they are proud of the work they do and don’t mind having it inspected. If a lab dodges these requests or is less than forthcoming, I would take my business elsewhere. You pay for transparent data collection, if a laboratory isn’t willing to show you everything that goes into generating that data, how can you have trust? Additionally, if a laboratory makes a mistake, and we all do, they should have a transparent process for investigating the root cause of the error and be willing to share that information with you as well.

What is the company’s quality assurance process to ensure each lab upholds the SC Labs standards?

That has been a big part of the lift in bringing labs into the fold that had been previously operating. We have a well established set of processes that have been refined over the past 12 years and we want customers to have the same experience, as much as is possible, when they test across the network. We also strive to be the leader in accuracy, turnaround times and efficiency. As such, we do come in and establish our SC Labs systems as quickly as possible. However, we have also been able to incorporate some best practices from each of the labs we’ve acquired. So, it has been a two way street in that regard and the process has made us much stronger overall in our technical operations.

Why and how did the company restructure the leadership team?

The original SC Labs leadership team is still involved in the day-to-day business. However, we have been able to add some experts to our executive team to really help us accelerate growth and that includes our new CEO, Jeff Journey. For the past 12 years, Jeff Gray served as our CEO and he looked forward to passing the reigns to Jeff Journey, in order to take the business to the next level. Jeff Gray’s new title is Chief Innovation Officer and he’s focused innovating our services portfolio as well as expanding our laboratory network. I have retained my role, overseeing the technical laboratory operations as well as regulatory and quality operations across the network. My title has changed from President to Chief Operations Officer. We’ve also been able to bring in additional executive support for Sales, Marketing, IT, and Finance which has helped us do things we just didn’t have the bandwidth or skill sets to accomplish until now. Additionally, our Chairman of the Board, Jeff Vail is an amazing executive and has had a huge impact on this growth stage for our company. Because he served as our interim CEO, he understands our business but also brings a fresh outside perspective.

What were the key traits and/or experience that SC Labs was looking for in the CEO hiring process?

Strong leadership experience with a track record of integrity and experience with a growth organization. It was also important to find someone who had experience leading science-based organizations.

What new perspective, wisdom, and/or skills does Jeff Journey bring to the team? How does the Board see Journey adding to the SC Labs brand?

We spent a lot of time searching for the perfect CEO for SC Labs. Obviously, as founders, we were emotionally invested in who was going to lead the company we spent the last 12 years building. I think we really found the best person for the job in Jeff Journey. He has a life sciences background and understands what it takes to get to where we want to go. He is intelligent and engaged and really proving to be a quick study in regards to the cannabis testing industry.

How do you hope to see SC Labs grow in the coming year, and how will this growth serve the cannabis industry?

The plan is to continue building what has already become the largest cannabis laboratory network in the country. We will continue to expand into the larger markets so we can offer customers the same experience in all of the places they operate as much as possible. I think our longevity and reputation for accuracy and integrity will help drive the lab industry in the markets in which we participate. Hopefully we can push the new labs to ‘up their game’ and they can do the same for us. In the end, the more high quality, high accuracy labs that are operating will benefit the end consumer, who want accurately labeled and safe products.


Thanks, Josh, for answering our questions today! Our audience can visit SCLabs.com to get in touch and/or learn more.

End


Cilicon Partners with Vape-Jet to Offer an Intelligent & Integrated Vaporizer Solution

Cilicon, a global provider of cannabis vapes hardware, and Vape-Jet, a U.S.-based infrastructure platform for cannabis oil-filling, announced today that they have entered into an official partnership to provide a smart, streamlined, and comprehensive product solution for cannabis brands around the world. The one-stop solution covers cannabis vaping technology development, hardware manufacturing, and filling machine designed to reduce the time and financial budget for industry practitioners focused on cannabis vaporization.

Cilicon has been dedicated to a comprehensive expansion of its cannabis vaporization product services offering to empower the cannabis community – both brands and consumers. Cilicon’s cannabis vape hardware business drives more than $200 million in sales annually across more than 150 global partners and 50 regions. With Cilicon, many more cannabis brands can lead the trend and evolution of cannabis vaporization with innovative vaping technology and product solutions. And, cannabis brands have more opportunities to expand their product lines, enhance their industry expertise and create more distinctive brand-signature products.

Having a mature, reliable, and intelligent product-supporting service is critical to the success of Cilicon’s one-stop product solution. By partnering with Vape-Jet, Cilicon now offers comprehensive product solutions, growing our network of providers and expanding our market analyses to inform hardware designs down the road. As a one-stop solution provider, Vape-Jet and Cilicon offer guaranteed hardware compatibility and standardized operating procedures, all under the unified mission to elevate your vape cartridge production. Vape-Jet’s professional equipment’s like Vape-Jet 4.0 Fully Automatic Cartridge Filling Machine, Jet Fueler 2.0 Semi-Automatic Cartridge Filling Machine, Squish-o-Matic 1000 Cartridge Capping Machine, will be combined with Cilicon’s technology and products to form more intelligent product services than ever. Cilicon’s brand partners can choose the appropriate service solutions according to their production conditions and manufacturing needs, optimizing the product mix, improving product quality, and shortening the time-to-market cycle.

“We aim to provide more integrated, hassle-free, smarter hardware from filling to vaping through our collaboration with Vape-Jet.” Chris Lin, Cilicon Chief Brand Officer, said, “This daily-changing industry requires us to work closer than ever to bring ‘real’ stuff to our cannabis vapor communities and cannabis companies. Working with Vape-Jet absolutely fits our values and culture, and we bond together to provide benefits to changing the industry pain points and unsolved problems. To make the whole journey from filling to final vaping easier and smarter.”

“Our crew has learned time and time again that we can work smarter by working together,” says Ryan Hoitt, Vape-Jet CEO, Developer and Founder. “By partnering with Cilicon we aim to prove that collaboration—rather than competition—will create better outcomes for our customers and provide smarter solutions for their production challenges. With our two companies equally dedicated to innovation and the power of technology, we look forward to working with Cilicon to lead this niche of the industry into the future.”

The Integrated Vape-Filling Solution by Cilicon and Vape-Jet is now available worldwide. For more information, please visit ciliconplus.com. To follow the latest Cilicon updates, please follow Cilicon’s official website.

About Cilicon
Cilicon was born with one dream: to improve everyday lives through vaporization technology with innovation, enthusiasm, and compassion. Innovation is in our blood. We are tired of inferior products driving out high-quality products and messing with the market. Therefore, Cilicon was founded without compromising quality, safety, and customer satisfaction. Cilicon derives a game-changing Cilicon Designed platform from generating diverse cannabis vaporizer options available for increasing customer brand competitiveness from the crowd. For Cilicon, your brand success is our priority. Your customer satisfaction matters!
For media inquiries: pr@ciliconplus.com

About Vape-Jet
At Vape-Jet data is at the forefront of everything we do. We focus on streamlining vape production by automating repetitive processes and eliminating inefficient procedures. Our rapid iteration process allows us to quickly apply the most advanced technological solutions to common industry challenges while continually evolving to meet the ever-changing demands of our customers. Vape-Jet filling machines are the most innovative, adaptive and accurate on the market, each one backed by our industry-leading proactive product support. Reach out to our crew to learn how you can start filling smarter.
For media inquiries: contact@vape-jet.com
For sales inquiries: sales@vape-jet.com

End


Poll: Majority of Texans Support Cannabis Legalization

A new poll reveals a majority of Texans support legalizing cannabis for medical and adult use, according to a Marijuana Moment report. The survey conducted by the University of Texas at Tyler and the Dallas Morning News found that 72% of registered voters support medical cannabis legalization, including 67% of Republicans.

Fifty-five percent of respondents say they would support legalizing cannabis for adult use. Republicans are split 48% against and 43% for adult-use legalization, while 65% of Democrats support broader legalization along with 63% of Independents.

The poll was conducted August 1-7 and consisted of 1,384 registered voters, with a margin of error of 2 percentage points. Other polls conducted in Texas have found support for adult use as high as 67%, with a slim majority of Republicans in favor, the report says.

Texas has been unable to advance any meaningful cannabis reforms on a state level. However, some local jurisdictions, including the state capital in Austin, have passed decriminalization measures, and some smaller Texas towns have decriminalization measures on the upcoming November ballots.

Former Democratic U.S. Rep. Beto O’Rourke has made the issue one of his top campaign pillars in his campaign for governor against incumbent Republican Gov. Greg Abbott. In January, Abbott said he did not believe low-level cannabis possession was the “type of violation” state officials “want to stockpile jails with.” As for O’Rourke, he said in his campaign announcement last year, that cannabis legalization was something “most of [Texans] actually agree on.”

End


Arizona Sets New Adult-Use Cannabis Sales Records While Medical Sales Fall

Medical cannabis sales in Arizona fell to their lowest total since January 2021 in May – slightly less than $45 million – only the second time in the past year they dropped below the $50 million mark, the Arizona Mirror reports. Adult-use sales in May topped $76.5 million, the fifth time they had surpassed the $70 million mark since the rollout of the industry at the beginning of last year.

The Arizona Department of Revenue also revised April’s adult-use sales figures to $81.2 million – up from the $75.5 million initially reported by officials that month – making it the best month for adult-use sales in the state yet.

Preliminary adult-use figures for June indicate $66.4 million in sales, which would represent they are on pace for another record, while preliminary medical cannabis sales figures are $33.7 million as they continue their seven-month downward trend.

The number of active medical cannabis cardholders in the state fell from 191,682 in June to 158,154 in July.

Total tax revenues for medical and adult-use sales in May were reported at $24.3 million, including $13.4 million from the 16% excise tax on adult-use sales, the report says. Year-to-date, the state has brought in $177.3 million from the excise tax on adult-use cannabis products.

Under the state’s legalization law, one-third of the cannabis taxes collected are earmarked for community college and provisional community college districts; 31% for public safety; 25% to the Arizona Highway User Revenue Fund, and 10% to the justice reinvestment fund, which is akin to a social equity program, used for public health services, counseling, job training, and other services for communities that have been most adversely impacted by the war on drugs.

End


New York Approves First 15 Cannabis Processor Licenses

New York cannabis regulators on Monday approved the first 15 conditional processor licenses for companies to design, manufacture, and package cannabis products.

Like the first round of cultivation licenses, the conditional licenses were given to companies that already hold hemp processing licenses. The processor-licensees also must participate in a mentorship program designed to provide pathways to the industry and entrepreneurship opportunities for social equity applicants and participate in an environmental sustainability program.

State regulators also approved interim regulations for cannabis processors after proposing the regulations for product packaging, labeling, marketing, advertising, and laboratory testing in June.

In a statement, Tremaine Wright, chair of the Cannabis Control Board said the regulation and license approvals bring the state “one step closer” to launching adult-use sales.

“Processors aren’t just an important part of the cannabis supply chain, they are creators, who take a raw plant and transform into tested, consistent, high-quality products that consumers can trust. When we open New York’s first stores, owned and operated by New Yorkers harmed by the misguided criminalization of cannabis, the shelves will be lined with infused edibles, topical creams and concentrated oils. None of those products would be possible without these first processors launching New York’s cannabis industry.” — Wright in a press release

The agency Monday also approved the opening of the application window for cannabis testing labs. Applicants need to prove documentation of ISO/IEC 17025 accreditation, proficiency testing for certain analytes, meet specific personnel requirements, and pay a non-refundable $1,000 application fee. 

Additionally, the state approved another 19 conditional cultivator licenses, bringing the total to 242. 

Jason Ambrosino, the founder of the Veterans Hemp Market, a New York-based group currently providing hemp flower products for military veterans, said in an email the group was “very excited and anxious to get to work.”

“NYS is one step closer to having a functional recreational cannabis industry, now all we need is a place to sell it,” he wrote.

 

End


Triton College Launches Cannabis Cultivation Course

Triton College, based in River Grove, Illinois, has launched a cannabis cultivation course as part of its greenhouse grow operations certificate program, the Wednesday Journal of Oak Park and River Forest reports. The program can be completed in five classes and can be spread over two semesters. 

Triton is among about a dozen community colleges in the state licensed by the Illinois Department of Agriculture and the Illinois Community College Board to offer cannabis courses. The college also offers a dispensary technician certificate program.  

Paul Jensen, associate vice president of academic innovation and workforce education at Triton, told the Journal that “large cannabis companies have been extraordinarily helpful to all the colleges that are growing and that are trying to train people.” 

“When there’s an opportunity for us to participate in a program that will give back to the community, we’re going to jump at the opportunity. We’re very excited to be able to get this license, bring this program here and work with the people in the community.” — Jensen to the Journal 

While colleges are not permitted to cultivate cannabis on campus, students enrolled in the program study plants similar to cannabis, and the college partners with cannabis craft growers which offer students tours of their facilities.

Allowing colleges to launch vocational pilot programs related to cannabis was included in the state’s legalization law. Students must be at least 18-years-old to enroll in cannabis coursework in Illinois.

End


Adult-Use Cannabis Sales In New Jersey Reach $80M During First 10 Weeks

Adult-use cannabis sales in New Jersey reached nearly $80 million during the first 10 weeks, from April 21 – the first day of sales – through June, according to the state Cannabis Regulatory Commission (CRC). Tax revenues derived from sales totaled $4,649,202 including $219,482 in Social Equity Excise Fees, the agency said.

Jeff Brown, CRC executive director, said New Jersey’s adult-use market is performing as regulators expected “with the current number of dispensaries, the spread of locations, and the high prices.”

“As more cannabis businesses come online, consumers won’t have to travel as far to make purchases, and prices will fall with increased competition. The market will do even better.” — Brown in a press release

Dianna Houenou, chair of the CRC, said the agency is working to get more adult-use businesses licensed and “are issuing awards to start new businesses on their path to operation and look forward to the industry growth we see coming in the near future.”

“New Jerseyans are looking forward to supporting new businesses,” she said, “which will increase sales figures and generate more revenue to be reinvested in our communities.”

Medical cannabis sales increased following the launch of adult-use sales after experiencing a small decline in the first quarter of the year, from $55,838,072 to $59,262,014, which the agency said represents totals “more in line with sales figures” in the last quarter of 2021.

Brown said regulators “are committed to ensuring access for patients,” adding that “the demand for medicinal cannabis continues to be strong.”

End


The Pitfalls of Cannabis Operations

Operations Ownership

After working directly with Oklahoma’s cannabis industry over the past couple of years, our firm thought it a good idea to pen an article articulating the most common and pressing issues we see in the industry.

Our experience comes from working with many cannabis companies in Oklahoma. Our work and experience is with well over one hundred cannabis companies in all segments of the Oklahoma market: Grow, Processing, Dispensary, Transportation, and Wholesale.

Cannabis operations face many hurdles not common to many other industries. One of the first and most problematic is being a mostly cash business.

Accounting / Cash Only (Mostly)

When cannabis began in Oklahoma, being cash only was not a choice. As banks were slow to open operations to cannabis operations, it was the only option. Even as the banks adapted to service the cannabis industry, it comes at quite a cost (especially when compared to any other business sector), often costing upwards of $1,000 per month, per account.

As banking has come more readily available, most of the clients we see have opted to move cash management and storage to banks. This, in our opinion, is a great move. However, even as banking has become a more popular option for cash storage, nearly all transactions are still conducted in cash. As cash is readily available in the businesses, it is easier to pay cash. Therefore, even as banking becomes available, cash management and receipt tracking are still one of the toughest areas for cannabis operations to manage.

Receipts and Proof of Expense

The largest issue of operating with all or mostly cash is keeping track of expenses. Without a bank or credit card statement, it is IMPERATIVE that you keep receipts! Without receipts, there is no expense (in the eyes of the IRS).

If your company is going to operate on cash, use old-school cash systems!! To ensure you can easily track and verify cash, consider the following procedures:

  • Cash Safe Log
    • All Cash that enters or exits the safe should be logged! Log the Date, Time, Amount In or Out, Person Removing Cash, and Reason for the Cash Move (Deposit from Owner, Deposit from Sales, Paid Joe Bob for 2 Pounds of Cannabis Flower, etc).
  • Register Cash Procedures
    • Beginning Cash should be the same at the start of every shift ($150.00)
      • Cash should be counted by the budtender and the manager, at the same time, and a signed receipt (by both) verifying the beginning balance).
    • Only 1 person can be allowed on a register (if more than one, even a manager, it erases the ability to track missing cash to one particular person).
    • The drawer should be pulled by the manager AND the budtender at the end of the shift, counted and a receipt signed by both parties verifying the ending totals.
    • A deposit should be made for each drawer for all cash in excess of the beginning cash ($150.00). A shift report from the Point of Sale (POS) should show the expected cash from the budtender’s shift, and should match the cash removed from the drawer for deposit, and should be dropped in a tamperproof bag. The drawer, with $150.00, should be placed in the safe or counted by the bud-tender coming on shift to verify it starts at the beginning cash ($150.00).
    • This cycle should be repeated for each drawer used.
    • All cash drops should be picked up and dropped in the safe (and entered in the safe log).
  • Purchase Journal
    • It is a great idea to keep a purchase journal for all cash purchases.
    • Track
      • Person Paid
      • Date
      • Amount
      • Purchase Description
      • Total Paid

As you can see, operating in an all or mostly cash operation requires quite a bit of additional work to ensure:

The Benefits of a Bank Account or Credit Card

The ability to use banking or credit cards for business operations is often taken for granted, by most businesses: most other businesses in the United States have cheap, convenient banking readily available to them wherever they are located.

Banking provides many positive benefits to businesses.

Filing all the Forms

8300 Forms

IRS Form 8300 are forms required for all transactions, in cash, totaling $10,000 or more. A common misconception is that a payment of less than $10,000 followed by an additional payment of less than $10,000 does not have to be reported. This is INCORRECT. (see this article: https://www.irs.gov/businesses/small-businesses-self-employed/irs-form-8300-reference-guide#:~:text=The%20law%20requires%20that%20trades,Escrow%20arrangement%20contributions)

Type of Payments to Report

Trades and businesses must report cash payments received if all of the following criteria are met:

  • The amount of cash is more than $10,000
  • The business receives the cash as:
    • One lump sum of more than $10,000, or
    • Installment payments that cause the total cash received within one year of the initial payment to total more than $10,000, or
    • Previously unreported payments that cause the total cash received within a 12-month period to total more than $10,000
  • The establishment receives the cash in the ordinary course of a trade or business
  • The same agent or buyer provides the cash
  • The business receives the cash in a single transaction or in related transactions

As you can see, any cash installment payment that totals $10,000 within a 12-month period of the first payment must report on form 8300 to the IRS.

Additionally, a new 8300 Form must be filed each time an additional $10,000 cash payment milestone is crossed. In essence, if someone pays you $25,000 in cash in a 12-month period, you would need to file two 8300 forms!

The 8300 form is required to be filed within 15 days of the $10,000 in cumulative payment being received.

Payroll (940 and 941)

All businesses paying employees need to file Federal Payroll Tax Returns. For most businesses, these are 940s (filed annually) and 941s (filed quarterly). Payments for these tax types are on a completely different schedule. Most businesses are required to make payments on a monthly or quarterly basis. The payments are called federal tax deposits, and all businesses are required to make federal tax deposits via the Electronic Federal Tax Payment System (EFTPS).

If a business makes a payment by any means other than EFTPS, even if the payment is made on time, they face a 10% penalty.

Max Freq. of cash payments by tax form (not for tax deposits, only tax due): https://www.irs.gov/payments/frequency-limit-table-by-type-of-tax-payment

How to make cash payments: https://www.irs.gov/payments/pay-your-taxes-with-cash

What to expect when you make a cash payment at in IRS office: https://www.irs.gov/payments/what-to-expect-when-you-pay-cash-at-an-irs-office

Where to make cash payments with retailers (up to $1k per day): https://www.irs.gov/payments/pay-with-cash-at-a-retail-partner

IRS Code – There Isn’t Any!

280E

Ok, prepare yourself. This is 280E!

No deduction or credit shall be allowed for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning of schedule I and II of the Controlled Substances Act) which is prohibited by Federal law or the law of any State in which such trade or business is conducted. (https://www.law.cornell.edu/uscode/text/26/280E)

Yep! That is it! 77 words! The whole of this much talked about “Cannabis Clause” is 77 words. Cannabis isn’t mentioned, but Schedule I and Schedule II drugs are.

Understanding 280E

Section 280E is a provision in the IRS Internal Revenue Code that stipulates any merchant selling goods considered a Schedule I or Schedule II controlled substance is not eligible to file for any tax deductions or tax credits beyond the cost of goods sold (COGS). Cost of goods sold are raw materials and supplies (seeds, clones, and fertilizer), equipment maintenance and repairs, utilities used to grow the cannabis, inspection and testing costs, and labor involved with cleaning, trimming, curing, packaging and supervisory wages. Keeping an accurate record of these expenses will help if you are ever audited and what accountants call Cost Accounting.

Understanding Cost Accounting

Section 471 of IRS Code
IRS Section 471 details how the IRS expects costs to be capitalized (in other words, booked as an asset and charged off as Cost of Goods Sold when sales are made. The good thing about section 471 for cannabis is this moves many costs that are typically booked as Operating Expense to inventory (expenses that are not allowed for Cannabis, thus Cost of Goods Sold; “expenses”/revenue adjustments that are allowed for cannabis).

The issue with section 471 for cannabis companies as this type of account will increase accounting costs.

Most businesses do not conform to GAAP (Generally Accepted Accounting Practices) in the United States. They simply are not required to do so. Cannabis, however, due to having most expenses disallowed, need to account more closely to GAAP than most small businesses, in order to avoid burdensome taxation: taxation that will literally break the bank.

Documentation (Court Case Rulings)

Most of the “rules” we apply to cannabis accounting and taxation today come from court case rulings. There are no “cannabis” rules in the IRS Tax code. Cannabis is never directly mentioned. IRS 280E is as close to mentioning as cannabis gets.

To begin with, this article is a good summary of some of the court cases, minus CHAMPS: (https://www.dopecfo.com/blog/lessons-in-compliance-from-4-notorious-cannabis-court-cases)

In regards to court cases, CHAMPS is a benchmark case for the cannabis industry. In CHAMPS, we learned how the IRS sees cannabis and related companies. CHAMPS most clearly detailed the way in which the IRS will consider a business a non-cannabis entity. CHAMPS involved a medical marijuana dispensary AND a clinic dedicated to helping people with debilitating diseases and conditions. The clinic employed the majority of the staff, had its own revenue stream, and was profitable without the dispensary sales or revenues.

When is my other business NOT a cannabis-taxed business?

In the CHAMPS case, the IRS Tax Court outlined that if a non-cannabis business is not entirely separate (own accounting books, checking accounts, business setup, etc) and cannot turn a profit without direct cannabis income, it IS a cannabis business. (Example, a business owner owns a dispensary and buys the building and puts it in its own company, then leases the building back to their own dispensary, the new “real estate” company is also taxed as cannabis income, as it cannot turn a profit with the income from the dispensary.

If, however, the building is owned by a company that has many rental locations and the real estate business can turn a profit without cannabis-related income, the real estate business is NOT a cannabis-taxed business under those conditions.

The biggest takeaway from Harborside was determining whether it was a single business or multiple separate entities, and how this holds up in the face of 280E. As the court held in CHAMPS, it is allowable to deduce many expenses not allowed under 280E if one is a real “non-trafficking” business. One of the biggest requirements for a “non-trafficking” business is that the activity conducted must be done regularly and consistently, stand on its own, and fully have the intent of making its own profit.

The courts have determined that a single legal entity can definitely operate more than one business based on these requirements. You can also have multiple legal entities that can be viewed as a single trade or business if they are aligned with the same profit motive. To this end, form over structure will hold up in court. The important thing to note is how the operations function as a unified business, rather than just how your entities are legally structured. (https://www.dopecfo.com/blog/lessons-in-compliance-from-4-notorious-cannabis-court-cases)

Documentation in your books: How Important is it?

One of the repeated phrases or criteria in nearly all of the IRS cannabis tax-related cases involved failure to document!

Several of the court cases involving marijuana had similar wording in the lost cases of businesses fighting IRS tax levies: a failure to document. This is a compelling and preventable phrase! The court said, in essence, if your books matched the case you presented in court, you would have a solid case. However, without documentation (proper accounting and tax filings for each reported year of operation), your expenses (Cost of Goods Sold adjustments) simply do not count: You cannot prove them!

Unfortunately, Olive did not clearly separate the businesses or account for them individually, leading to the Ninth Circuit holding that the owner of the business was not able to mitigate any tax liability because their business consisted solely of trafficking marijuana. Olive suggested that the Ninth Circuit apply their ruling on a previous U.S. Tax Court case, Californians Helping to Alleviate Medical Problems, Inc. (C.H.A.M.P.) v. Commissioner (a case Cannabis industry had won in which separate entities were found to be compliant), but the Tax Court did not agree with the IRS’s and Olive’s estimates, deciding on its own determined COGS amount and determining that none of Olive’s expenses were tax deductible. (https://www.dopecfo.com/blog/lessons-in-compliance-from-4-notorious-cannabis-court-cases)

Other Articles:

Tax Court decisions upholding 280E and Business deductions:
CANNABIS TAX ALERT: Tax Court Decision Upholds 280E and Business Deductions | MGO (mgocpa.com)

Other Articles by Vertices Co:
https://verticesco.com/accounting-for-medical-cannabis-businesses-explained/

End


Canapa Launches High Precision Pre-Roll Check Weigher

New ‘Pre-Roll Inspector’ Accurate to 0.01 Gram

August 10, 2022 – Canapa has announced an addition to its industry-leading series of check weighing machines, the WeightCheQ 0-250. Engineered with electromagnetic force restoration (EMFR) technology to achieve incredibly tight 0.01-gram tolerances, this high-precision machine ensures a more accurate, consistent pre-roll is delivered for final retail packaging.

The WeightCheQ can be easily paired with any semiautomated pre-roll machine or manual rolling process to double-check pre-roll weights, eliminating product waste while increasing margins.

This technology is also perfectly suited to precisely weigh gummies, capsules and other cannabis products with seamless integration into existing bagging, container filling, flow wrapping and case filling systems.

In addition to innovative EMFR weigh cell technology, this machine features a robust stainless-steel frame construction, food grade belts, integrated rejection lighting system, 15-inch color touchscreen with display to three decimal points, storage for up to 20 different recipes and does not require compressed air to operate.

To watch video of the WeightCheQ 0-250 and learn more about other pre-roll solutions from Canapa, visit www.canapasolutions.com/check-weigher.

End


Report: Medical Cannabis Sector Expected to Reach $24.86B by 2027

The worldwide medical cannabis sector is expected to be worth $24.86 billion by 2027, according to a new Research and Markets report. Starting at a 2022 sales estimate of $2.91 billion, the figure represents a compound annual growth rate of 20.9%.

The data was gathered from multiple countries across several continents, including some of the world’s largest medical cannabis markets such as Germany, the U.S., Spain, the United Kingdom, Australia, Israel, Thailand, and Denmark. The report also included lesser-known countries that allow medical cannabis access and those that still prohibit medical cannabis, such as Russia and countries in the Middle East and Africa.

The report says some of the growth is due to an increased demand for cannabis compounds, an increase in population and accompanying diseases, and rising awareness about the benefits of medical cannabis.

The report does warn, however, that the high price of medical cannabis may act as an impediment to growth over the next five years. Other challenges facing industry growth, the report says, are rising energy prices and issues with maintaining product consistency.

Earlier this year, a MarketsandMarkets report predicted that the global cannabis industry — encompassing both medical and adult-use sales — would reach $90.4 billion by the year 2026.

End


Missouri Cannabis Campaign Data Suggests Legalization Will Pass in November

With Missouri voters set to vote on cannabis legalization in November, independent polling suggests the reforms will pass. Dan Viets, an attorney and executive director of Missouri NORML, told the Columbia Daily Tribune that internal polling data show 62% of Missouri voters back adult-use reforms.

The data is on par with a SurveyUSA poll released in May which found the same level of support for cannabis legalization in the state. That poll found 76% of Democrats supported adult-use legalization, with 14% opposed along with 49% of Republicans (38% opposed) and 66% of independent voters (20% opposed).

“We’re not taking anything for granted, but the data we have certainly indicated we have a good chance of passage. … The national polling shows close to half of Republicans support legalizing marijuana.” — Viets to the Daily Tribune

Viets added that the measure “will likely do better in more educated areas of the state, but support is really broad.”

In Missouri, Viets said, 20,000 people are arrested annually for “usually very small amounts of marijuana” and that, if approved, the measure will “expunge the criminal records of hundreds of thousands of people with marijuana convictions.” The measure includes provisions allowing expungement of low-level, non-violent, cannabis crimes.

In 2020, the American Civil Liberties Union reported that Black people in Missouri are 2.6 times more likely to be arrested for cannabis possession than white people.

The language that will appear on ballots along with the question says state governmental entities estimate initial costs of the adult-use program at $3.1 million with initial revenues of at least $7.9 million, annual costs of $5.5 million, and annual revenues of at least $40.8 million. Local governments are estimated to have annual costs of at least $35,000 and annual revenues of at least $13.8 million.

End


Washington Considers Point System for Social Equity Cannabis Licenses

The Washington State Liquor and Cannabis Board (LCB) is considering a program to allow individuals convicted of a cannabis-related crime and who served prison time preferential licensing for adult-use cannabis permits, FOX 13 reports. Brian Smith, director of communications for the LCB, noted that the agency is holding 40 licenses for social-equity applicants.

“Our intent is to be able to reach applicants that were disproportionally harmed by the war on drugs.” — Smith to FOX 13

The license consideration by the LCB comes as lawmakers in Seattle are considering their own social equity package. If the LCB adopts the new regime, the city will adopt the same rules and set aside $1 million in grant money for social equity licensees, the report says.

In 2020, state lawmakers created the Washington State Legislative Task Force on Social Equity in Cannabis which makes recommendations to the LCB on the issuance of retail cannabis licenses. The preferential licenses were pitched by the task force.

Smith indicated that there are several criteria an applicant needs to qualify including living in an area that was disproportionally harmed by the war on drugs. He said that the University of Washington is currently developing a map of where those areas in the state are located.

Another criterion of the proposed rule includes social equity applicants or a family member of the applicant having been arrested or convicted of a cannabis offense.

Applicants will be scored on a point system and the way the rule is proposed, individuals that were incarcerated for cannabis crimes will get additional points. If a person was fined for a cannabis offense, it’s 10 points, if they served probation, it’s 20 points, if they were sentenced to home detention, it’s 40 points, and for those who served time in jail or prison, it’s 80 points.

The LCB is set to hold a public hearing on the proposal on September 14.

End


The Weed Gummies Cookbook: Recipes for Cannabis Candies, THC and CBD Edibles, and More

Desperately seeking relief for a herniated spinal disk and finding none among the cocktail of opioids prescribed by her doctor, Monica Lo’s world changed after she received a cannabis-infused treat from her roommate.

“For the first time in a long time, I slept like a baby,” she says. “The next day, I found myself spending hours upon hours researching this plant and how to make my own infusions. Since we lived in a strict no-smoking building, I needed to be very discreet with the wafting scent of cannabis; this meant that using a Crock-Pot or cooking on the stovetop was not in the cards.”

Lo was a creative director of a sous vide start-up and thought she’d put the company’s machines to the test, which inspired her to start her educational blog Sous Weed®.

Now, she is sharing her culinary creations in The Weed Gummies Cookbook: Recipes for Cannabis Candies, THC and CBD Edibles, and More [978-1-64604-366-8; $17.95; Ulysses Press; August 2022], a practical collection of recipes for those at various stages of their cannabis journey, offering approachable ways to incorporate a variety of cannabinoids into your routine. With the help of step-by-step instructions and color photos, you’ll also get pro tips for safely handling and labeling your confections.

The Weed Gummies Cookbook will inspire you to create your own special gummies and candies that are even better than your average dispensary-bought treats. You’ll find weed-infused recipes like Sour Green Apple Gummies; Lavender Chamomile Sleep Gummies; Mocha Caramels; Honey Elderberry Lozenges, and much more.

“The main reason for DIY is that it’s far more cost-effective to make your infusions and treats at home, especially as dispensary prices skyrocket,” Lo says. “This user-friendly cookbook is designed to build your culinary cannabis repertoire and help you feel empowered to make your edibles at home.”

With clear instructions, warm anecdotes with each recipe, and an advance warning before the tricky bits, Lo becomes your trusted friend on your exciting cannabis journey.

A portion of the profits from The Weed Gummies Cookbook will be donated semi-annually to the Last Prisoner Project.

The Weed Gummies Cookbook: Recipes for Cannabis Candies, THC and CBD Edibles, and More by Monica Lo
Ulysses Press
Paperback; August 30, 2022
ISBN: 978-1-64604-366-8
$17.95; 6 x 8; 128 pages

End


Tilray CEO: U.S. Represents ‘$100B Opportunity in Cannabis’

During an appearance on Yahoo Finance Live, Tilray CEO Irwin Simon called the U.S. “a $100 billion opportunity in cannabis.” Simon also suggested that traditional firms, such as “the Nestles and Unilevers” will seek to enter the cannabis space “because they know Gen-Z, millennials, that’s very much what they want.”  

“If you look at cannabis today in the U.S., 93% of Americans want medical cannabis legalized and about 63%, 65% want adult use. Today, it’s legal in about 33 states, plus D.C. So it’s out there that… a majority of people want cannabis legally.” — Simon to Yahoo Finance Live 

Simon noted that in Canada, where Tilray currently operates, the cannabis industry has “contributed about $20 billion in taxes, over 150,000 jobs, [and] about $6 billion in infrastructure.”  

Curaleaf CEO Matt Darin told Yahoo Finance that the firm, one of the largest cannabis companies in the U.S., is “very encouraged by what’s coming out of Washington, D.C. currently.”  

“There’s never been more bipartisan support for sensible reforms,” he said.

In July, U.S. Senate leaders filed a cannabis legalization bill that would decriminalize cannabis federally and allow states to set their own policies, but the measure faces a tough road in the chamber where the filibuster rules require 60 votes for legislation to pass. Democrats hold a one-vote majority as Vice President Kamala Harris serves as the tie-breaking 51st vote but several Democrats, including Sens. Jeanne Shaheen (NH), Joe Manchin (W.VA), and Bob Casey (PA) may not support the reforms. 

The House has twice passed a cannabis legalization bill – the MORE Act – but it has never been voted on in the Senate. 

End


Curaleaf Removes Thousands of New York Products With Unapproved Potency Labels

New York medical cannabis company Curaleaf has been forced to pull tens of thousands of units of cannabis from dispensary shelves after it switched to a new way of labeling product potency without approval from state regulators, Syracuse.com reports. Curaleaf began using “dry weight” measurements on its products in July but the company had not received Office of Cannabis Management (OCM) approval.  

While all medical cannabis products sold in New York show “wet weight” measurement, the “dry weight” method shows significantly higher THC percentages, the report says. For example, using wet weight measurement, a product could show a 20% THC percentage but that same product could show a THC percentage as high as 37% using dry weight testing.  

Stephanie Cunha, a Curaleaf spokesperson, told Syracuse.com that dry weight “is considered the most accurate metric for THC content on any type of cannabis sample.” She added that Connecticut, New Jersey, and Maryland also use the dry weight method.  

Bob Miller, the COO of ACT Laboratories, told Syracuse.com that from a laboratory perspective, dry weight allows more accurate product-to-product or lab-to-lab comparisons but said the “downside of the approach” is that the method inflates potency which “is misleading to the patients.” 

In late July, the OCM said that dry weight measurements “are for informational purposes only and cannot be applied to approved product labeling until such time an approved method is available.” The agency ordered the removal of the products that used the dry weight method but said they could be redistributed “with the New York mandated wet weight measurement,” Cunha said.     

End


31 Rhode Island Municipalities to Vote on Allowing Local Cannabis Sales in November

Thirty-one Rhode Island municipalities will vote in November on whether to allow cannabis sales in their jurisdiction, WPRI reports. The cities and towns must decide whether to opt out or they will not be able to prohibit retail cannabis sales in their communities.

The towns that will vote on allowing cannabis sales include:

  • Barrington 
  • Bristol 
  • Burrillville 
  • Charlestown 
  • Coventry 
  • Cumberland 
  • East Greenwich 
  • East Providence 
  • Glocester 
  • Hopkinton 
  • Jamestown 
  • Johnston 
  • Lincoln 
  • Little Compton 
  • Middletown 
  • Narragansett 
  • Newport 
  • New Shoreham 
  • North Kingstown 
  • North Providence 
  • North Smithfield 
  • Richmond 
  • Scituate 
  • Smithfield 
  • South Kingstown 
  • Tiverton 
  • Warren 
  • Westerly 
  • West Greenwich 
  • West Warwick 
  • Woonsocket 

Rhode Island lawmakers approved adult-use cannabis legalization legislation in May and Gov. Dan McKee (D) signed the reforms into law two days later. Under the measure, adults 21 and older can purchase and possess up to an ounce of cannabis and keep 10 ounces at home for personal use. Adults can also cultivate up to six plants at home, including three mature and three immature plants. The state will license 33 retailers across six zones and impose a 10% excise tax, along with the state’s 7% sales tax, and a 3% tax which would go to municipalities. 

Towns and cities that opt out of sales are not eligible for any of the revenue from retail cannabis sales. An early fiscal note on the bill estimated first-year sales – from 2023 to 2024 – would lead to $14 million in new revenue for Rhode Island with cities and towns each receiving about $2.5 million. 

End


Arkansas Supreme Court Conditionally Allows Cannabis Legalization Question on Ballots

The Arkansas Supreme Court is allowing the adult cannabis use question on November ballots conditionally while it decides whether the state Board of Election Commissioners’ decision to reject the proposal was valid, 5News reports. In its order, the court said it would make its final determination by August 25. 

In rejecting the popular name and ballot title – which blocked the question from ballots despite the initiative garnering more than 100,000 signatures than was required – the commissioners said they didn’t think the title fully explained the proposed constitutional amendment, claiming that the measure would repeal the state’s current THC limit on medical cannabis products. 

In their lawsuit challenging the decision, Responsible Growth Arkansas argued the board used an “overly stringent” approach in their decision-making that violated the state constitution. The lawsuit also challenges a 2019 law that gives the board the power to certify ballot initiatives. Prior to the 2019 law, ballot measures had to be reviewed by the state attorney general prior to the circulation of petitions. The campaign also argues that the board’s decision was “incorrect” because it prevents “hundreds of thousands of Arkansans to have the opportunity to vote on the Amendment,” the report says.  

Responsible Growth Arkansas attorney Steve Lancaster previously said that the board’s decision was unfair because it would require the title to go into too much detail, saying “the type of detail that the board expected, or demanded in this case, would make [the] ballot title thousands and thousands of words long.”  

“That just simply is not workable for a ballot,” he said. 

End


Maine Offering Towns $20k to Allow Adult-Use Cannabis Businesses

Maine’s Office of Cannabis Policy is offering municipalities that allow adult-use cannabis sales up to $20,000 to help regulation costs, Spectrum News reports. Cities and towns can use the funds to cover the costs of attorneys, drafting ordinances, staff time, and other expenses, and officials hope it could incentivize those that do not allow industry operations within their borders to reconsider.

Currently, just 7% of Maine cities and towns have opted in to allow adult-use cannabis sales, the report says.

In a press release, Erik Gundersen, state cannabis office director, said that “the reality is, no matter if a town has opted in or not, there is cannabis being bought, sold and consumed there.” 

“The most important thing we can do is try and ensure that Mainers who choose to use cannabis can do so in a well-regulated environment that safeguards public health and safety in the best way possible.” — Gundersen, in a statement, via Spectrum News 

Kate Dufour, director of Advocacy and Communications for the Maine Municipal Association, said that the $20,000 in reimbursement funds is a “cold comfort” and that municipalities “wanted more” – potentially in the form of enhanced revenue sharing.

“I think communities have made up their minds,” she told Spectrum News. “They are either in or out.” 

In July, adult-use cannabis sales in Maine totaled $16.3 million with 247,401 transactions. So far this year, sales have reached $81 million with more than 1.2 million transactions, according to state data outlined by Spectrum News. 

End


Massachusetts Governor Signs Cannabis Industry Reform Bill

Massachusetts Gov. Charlie Baker (R) on Thursday signed the bill package of cannabis industry reforms, which includes social-equity provisions, tax reforms for the industry, and a reworking of the state’s host community agreements, Axios reports. The measure also includes a re-tooling of how the state expunges previous cannabis convictions and includes a pilot program for cannabis cafés.  

The new law alters the state tax code so cannabis businesses can write off business expenses like non-cannabis firms. Previously, the state did not allow cannabis businesses to take normal business deductions.

Under the law, communities can still impose a limited-time “impact fee” on cannabis businesses that seek to open shop in their municipality, but that fee is now limited to 3% of the business’s total sales. The so-called community host agreements came under fire following the arrest, and ultimate conviction, of former Fall River Mayor Jasiel Correia who extorted cannabis businesses under the guise of the host agreement.

Baker did veto part of the bill that would have led to a study on pediatric medical cannabis consumption in schools.

“I support many of the provisions this bill adopts to improve regulation of the cannabis industry, and I support the bill’s efforts to expand opportunities for social equity businesses. I have serious concerns, however, about [the study]. The language of the section is highly prescriptive – making it clear that the agencies charged with producing the study must identify ways to make medical marijuana widely available within schools, rather than considering whether such an allowance is advisable.” — Baker, in a signing statement, via the Boston Globe  

Lawmakers had approved the omnibus cannabis bill unanimously in the Senate and 153-2 in the House. Massachusetts lawmakers could decide to try and override Baker’s veto of the section providing for the study, but the state’s formal session has ended. 

End


Members of the Crow Tribe Seeking to Open Cannabis Dispensary in Montana

Members of the Crow Tribe are seeking to open the first cannabis dispensary on tribal land more than eight months after adult-use sales began in Montana, KTVQ reports. Silverleaf Apsaalooke submitted the plans several months ago but are still awaiting approval from the Crow Tribe. 

Dylan Jefferson, a partner in Silverleaf, noted that the land they are hoping to start the business on is owned by a non-tribal member and that the Bureau of Indian Affairs and tribe “supposedly” don’t have jurisdiction over the site.  

The tribe was the first indigenous nation in Montana to pass an ordinance to allow dispensaries after voters approved the reforms in 2020. The state Legislature passed a law that same month allowing one cannabis business license to each tribal government in the state; however, those licenses are restricted to the lowest cultivation tier structure under the state’s adult-use cannabis law.  

So far, however, the business has not been able to get approval from the tribe, which the state Department of Revenue is requiring because customers would have to pass through tribal lands in order to get to the shop. The agency is also requiring permission from Big Horn County. 

Jefferson said because the business is privately owned it would not affect the tribe’s ability to get their own license. He described the silence from the tribe as frustrating. 

James Vallie, another partner in Silverleaf, told KTVQ that the business owners are ready to “turn on the lights right now.”    

“We just need that letter (from the tribe) or the state just needs to give us the license,” he said. 

End


New Jersey University Files Lawsuit to Stop Cannabis Business from Opening Near Dorms

New Jersey’s Saint Peter’s University last week filed a lawsuit against a commercial cannabis applicant and the Jersey City Planning Board over the company’s plans to open a dispensary and lounge near the college’s dormitories, according to the Hudson Reporter. The lawsuit names Medusa NJ and the planning board, arguing that the board’s approval of the business was “arbitrary and capricious” on several counts, and is asking the court to void it.  

Haytham Elgawly, the owner of Medusa, is seeking to convert his clothing store into a retail cannabis store and consumption lounge, which the university has opposed since it was proposed in April. The planning board approved Elgawly’s application despite the college’s opposition. 

During an appearance before the city’s Cannabis Control Board in June, University President Eugene Cornacchia said the college opposed the cannabis businesses over concerns about crowd control and security for students living in residence halls. 

In the lawsuit, attorneys for Saint Peter’s argue that the Planning Board approval violates a city ordinance requiring a dispensary’s main door to be within 200 feet from a school based on the city’s Drug-Free School and Park Zone Map and that Medusa’s door would be just 65 feet from one of the college’s dorms. The lawsuit alleges that the Planning Board used a map called the Cannabis Retail Buffer Map that did not include colleges and universities. 

The lawsuit further claims that the board did not consider the “negative impact” of the businesses on the college’s under-21 student population and the wider community, the report says.      

Medusa has received a conditional license from New Jersey but still needs final approval from the City Council. 

End


Arkansas Medical Cannabis Sales Reach $23.3M in July

Medical cannabis sales in Arkansas reached $23.3 million last month, according to Health Department data outlined by 5News. The total exceeds the $22 million in sales realized in June. 

Scott Hardin, spokesperson for the Arkansas Department of Finance and Administration, told 5News that Arkansans spent an average of $751,720 per day on medical cannabis in July and since January 1, patients have spent a total of $157.9 million on 27,782 pounds from the state’s 38 dispensaries.  

Natural Relief Dispensary in Sherwood led the state in pounds sold in July with 392.64 pounds, followed by the ReLeaf Center in Bentonville (308.61 pounds), CROP in Jonesboro (281.83), Suite 443 in Hot Springs (281.08 pounds), and Green Springs Medical in Hot Springs (217.77). 

Earlier this month, Responsible Growth Arkansas submitted enough signatures to put an adult-use legalization question on November ballots; however, the state Board of Election Commissioners rejected the initiative’s popular name a ballot title, claiming it didn’t fully explain the constitutional amendment and that the measure would repeal the state’s current THC limit on medical cannabis products. The decision by the board effectively bars the question from ballots.  

Following the board’s decision, the campaign filed a lawsuit in the state Supreme Court challenging that decision, saying the commissioners used an “overly stringent” approach that violates the state constitution. The lawsuit also challenges the 2019 law that gave the board the power to certify ballot initiatives. Prior to the 2019 law, ballot measures had to be reviewed by the state attorney general prior to the circulation of petitions. 

Earlier this week a separate lawsuit was filed that could doom the state’s medical cannabis industry. The lawsuit seeks to use the Racketeer Influenced and Corrupt Organizations Act, commonly known as RICO, to target medical cannabis companies plaintiffs accused of deceptive trade practices. The lawsuit claims some medical cannabis was sold in Arkansas with a potency different than what was advertised – a deceptive trade practice – and that cannabis businesses are subject to RICO because cannabis is federally outlawed.    

End